Home › PsychoGenics Achieves Another Milestone In Drug Discovery Collaboration With Sunovion
 

Keywords :   


PsychoGenics Achieves Another Milestone In Drug Discovery Collaboration With Sunovion

2015-02-04 06:21:29| drugdiscoveryonline Home Page

PGI Drug Discovery LLC (PsychoGenics), recently announced the achievement of a milestone in its drug discovery and development collaboration with Sunovion Pharmaceuticals Inc. In August 2007, PsychoGenics and Sunovion entered into a drug discovery and development agreement to combine their complementary strengths and expertise to identify a new generation of treatments for neuropsychiatric disorders

Tags: with drug collaboration discovery

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Print Quest invests in two more Miraclon Shine LED lamp kits
03.07ETI celebrates grand opening of new headquarters in Spain
03.07Mondi unveils FlexiBag Reinforced
03.07Nilpeter announces new partnership in the Philippines
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 20
03.07Hurricane Beryl Public Advisory Number 20
03.07Summary for Hurricane Beryl (AT2/AL022024)
More »